Martinez, Fernando J
- Weill Cornell Medicine · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,795
- Rising Star
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$3M
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#1,795
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Martinez, Fernando J as a PI. Multi-PI records show the full award amount for context.
- 5UH3HL145266-04UH3Contact PI1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases studyWeill Cornell Medicine · Internal Medicine (NIH department code)$3Maward amount
Award organization
Organizations that administered FY2023 awards listing Martinez, Fernando J as a PI.
FY2023 award administered by Weill Cornell Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardWeill Cornell Medicine
- 2006$500K Cumulative Funding
- 2006Entered Top 50% NationallyRanked #5993
- 2007$1M Cumulative Funding
- 2008$2M Cumulative Funding
- 2021$5M Cumulative Funding
- 2021Entered Top 25% NationallyRanked #2010
- 2022Entered Top 10% NationallyRanked #1356
- 2023$10M Cumulative Funding